These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 28805527)

  • 1. Bias, misleading information and lack of respect for alternative views have distorted perceptions of myalgic encephalomyelitis/chronic fatigue syndrome and its treatment.
    Goudsmit E; Howes S
    J Health Psychol; 2017 Aug; 22(9):1159-1167. PubMed ID: 28805527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PACE trial claims for recovery in myalgic encephalomyelitis/chronic fatigue syndrome - true or false? It's time for an independent review of the methodology and results.
    Shepherd CB
    J Health Psychol; 2017 Aug; 22(9):1187-1191. PubMed ID: 28805522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do graded activity therapies cause harm in chronic fatigue syndrome?
    Kindlon T
    J Health Psychol; 2017 Aug; 22(9):1146-1154. PubMed ID: 28805516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic fatigue syndrome patients have no reason to accept the PACE trial results: Response to Keith J Petrie and John Weinman.
    Agardy S
    J Health Psychol; 2017 Aug; 22(9):1206-1208. PubMed ID: 28805512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PACE investigators' response is misleading regarding patient survey results.
    Kirke KD
    J Health Psychol; 2017 Aug; 22(9):1168-1176. PubMed ID: 28805528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PACE team response shows a disregard for the principles of science.
    Edwards J
    J Health Psychol; 2017 Aug; 22(9):1155-1158. PubMed ID: 28805520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PACE trial authors continue to ignore their own null effect.
    Vink M
    J Health Psychol; 2017 Aug; 22(9):1134-1140. PubMed ID: 28805519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PACE-GATE: An alternative view on a study with a poor trial protocol.
    Stouten B
    J Health Psychol; 2017 Aug; 22(9):1192-1197. PubMed ID: 28805525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the scientific rigour of randomized controlled trials on the effectiveness of cognitive behavioural therapy and graded exercise therapy for patients with myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review.
    Ahmed SA; Mewes JC; Vrijhoef H
    J Health Psychol; 2020 Feb; 25(2):240-255. PubMed ID: 31072121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The problem of bias in behavioural intervention studies: Lessons from the PACE trial.
    Wilshire C
    J Health Psychol; 2017 Aug; 22(9):1128-1133. PubMed ID: 28805526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to the editorial by Dr Geraghty.
    White PD; Chalder T; Sharpe M; Angus BJ; Baber HL; Bavinton J; Burgess M; Clark LV; Cox DL; DeCesare JC; Goldsmith KA; Johnson AL; McCrone P; Murphy G; Murphy M; O'Dowd H; Potts L; Walwyn R; Wilks D
    J Health Psychol; 2017 Aug; 22(9):1113-1117. PubMed ID: 28805524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PACE trial of treatments for chronic fatigue syndrome: a response to WILSHIRE et al.
    Sharpe M; Goldsmith K; Chalder T
    BMC Psychol; 2019 Mar; 7(1):15. PubMed ID: 30871632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myalgic encephalomyelitis/chronic fatigue syndrome patients' reports of symptom changes following cognitive behavioural therapy, graded exercise therapy and pacing treatments: Analysis of a primary survey compared with secondary surveys.
    Geraghty K; Hann M; Kurtev S
    J Health Psychol; 2019 Sep; 24(10):1318-1333. PubMed ID: 28847166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PACE trial: It's time to broaden perceptions and move on.
    Petrie KJ; Weinman J
    J Health Psychol; 2017 Aug; 22(9):1198-1200. PubMed ID: 28805523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distress signals: Does cognitive behavioural therapy reduce or increase distress in chronic fatigue syndrome/myalgic encephalomyelitis?
    Laws KR
    J Health Psychol; 2017 Aug; 22(9):1177-1180. PubMed ID: 28805513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further commentary on the PACE trial: Biased methods and unreliable outcomes.
    Geraghty KJ
    J Health Psychol; 2017 Aug; 22(9):1209-1216. PubMed ID: 28805517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protocol for the PACE trial: a randomised controlled trial of adaptive pacing, cognitive behaviour therapy, and graded exercise, as supplements to standardised specialist medical care versus standardised specialist medical care alone for patients with the chronic fatigue syndrome/myalgic encephalomyelitis or encephalopathy.
    White PD; Sharpe MC; Chalder T; DeCesare JC; Walwyn R;
    BMC Neurol; 2007 Mar; 7():6. PubMed ID: 17397525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive behaviour therapy and objective assessments in chronic fatigue syndrome.
    McPhee G
    J Health Psychol; 2017 Aug; 22(9):1181-1186. PubMed ID: 28805529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigator bias and the PACE trial.
    Lubet S
    J Health Psychol; 2017 Aug; 22(9):1123-1127. PubMed ID: 28805514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defense of the PACE trial is based on argumentation fallacies.
    Lubet S
    J Health Psychol; 2017 Aug; 22(9):1201-1205. PubMed ID: 28805515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.